Published in Kidney Int on March 01, 1994
Loss of MicroRNA-192 promotes fibrogenesis in diabetic nephropathy. J Am Soc Nephrol (2010) 2.45
Integrin alpha1beta1 and transforming growth factor-beta1 play distinct roles in alport glomerular pathogenesis and serve as dual targets for metabolic therapy. Am J Pathol (2000) 1.90
Divergent roles of Smad3 and PI3-kinase in murine adriamycin nephropathy indicate distinct mechanisms of proteinuria and fibrogenesis. Kidney Int (2012) 1.66
Myofibroblast proliferation, fibrosis, and defective pancreatic repair induced by cyclosporin in rats. Gut (1999) 1.66
Origin of interstitial fibroblasts in an accelerated model of angiotensin II-induced renal fibrosis. Am J Pathol (2005) 1.64
Platelet-derived growth factor-BB induces renal tubulointerstitial myofibroblast formation and tubulointerstitial fibrosis. Am J Pathol (1996) 1.49
The role of the B7 costimulatory pathway in experimental cold ischemia/reperfusion injury. J Clin Invest (1997) 1.42
A mutant, noninhibitory plasminogen activator inhibitor type 1 decreases matrix accumulation in experimental glomerulonephritis. J Clin Invest (2003) 1.42
TGF-beta signal transduction in chronic kidney disease. Front Biosci (Landmark Ed) (2009) 1.41
Endothelin-1 transgenic mice develop glomerulosclerosis, interstitial fibrosis, and renal cysts but not hypertension. J Clin Invest (1997) 1.37
Hypoxia increases human keratinocyte motility on connective tissue. J Clin Invest (1997) 1.27
Noncanonical TGF-beta pathways, mTORC1 and Abl, in renal interstitial fibrogenesis. Am J Physiol Renal Physiol (2009) 1.27
Vascular consequences of dietary salt intake. Am J Physiol Renal Physiol (2009) 1.25
A PAI-1 mutant, PAI-1R, slows progression of diabetic nephropathy. J Am Soc Nephrol (2008) 1.24
Dual roles of immunoregulatory cytokine TGF-beta in the pathogenesis of autoimmunity-mediated organ damage. J Immunol (2008) 1.19
Proteinuria as a predictor of disease progression in children with hypodysplastic nephropathy. Data from the Ital Kid Project. Pediatr Nephrol (2003) 1.15
Hyaluronan attenuates transforming growth factor-beta1-mediated signaling in renal proximal tubular epithelial cells. Am J Pathol (2004) 1.13
Renal ischemia-reperfusion injury upregulates histone-modifying enzyme systems and alters histone expression at proinflammatory/profibrotic genes. Am J Physiol Renal Physiol (2009) 1.10
Follistatin improves skeletal muscle healing after injury and disease through an interaction with muscle regeneration, angiogenesis, and fibrosis. Am J Pathol (2011) 1.07
Kidney fibrosis in hypertensive rats: role of oxidative stress. Am J Nephrol (2008) 1.07
Increased expression of transforming growth factor beta s after acute oedematous pancreatitis in rats suggests a role in pancreatic repair. Gut (1997) 1.07
Autoantibodies and resident renal cells in the pathogenesis of lupus nephritis: getting to know the unknown. Clin Dev Immunol (2012) 1.05
Sequential expression of cellular fibronectin by platelets, macrophages, and mesangial cells in proliferative glomerulonephritis. Am J Pathol (1994) 1.02
Mesangial cell integrin αvβ8 provides glomerular endothelial cell cytoprotection by sequestering TGF-β and regulating PECAM-1. Am J Pathol (2011) 1.00
Myofibroblasts in experimental hydronephrosis. Am J Pathol (1995) 1.00
Evaluation of metalloprotease inhibitors on hypertension and diabetic nephropathy. Am J Physiol Renal Physiol (2011) 0.99
Gene discovery and vesicoureteric reflux. Pediatr Nephrol (2008) 0.96
Semiautomatic quantitation of macrophages in human renal biopsy specimens in proteinuric states. J Clin Pathol (1997) 0.92
Lipoxin A4 modifies platelet-derived growth factor-induced pro-fibrotic gene expression in human renal mesangial cells. Am J Pathol (2005) 0.92
TGF-β/Smad3 activates mammalian target of rapamycin complex-1 to promote collagen production by increasing HIF-1α expression. Am J Physiol Renal Physiol (2013) 0.91
Ubiquitin-dependent degradation of Smad2 is increased in the glomeruli of rats with anti-thymocyte serum nephritis. Am J Pathol (2003) 0.90
Aldosterone induces mesangial cell apoptosis both in vivo and in vitro. Am J Physiol Renal Physiol (2008) 0.89
Expression of alternatively spliced fibronectin variants during remodeling in proliferative glomerulonephritis. Am J Pathol (1995) 0.86
Extracellular matrix and the kidney. J Clin Pathol (1996) 0.86
Biomarkers for incident CKD: a new framework for interpreting the literature. Nat Rev Nephrol (2013) 0.85
Diabetic nephropathy. Mechanisms of mesangial matrix expansion. West J Med (1995) 0.84
Unexpected news in renal fibrosis. J Clin Invest (2002) 0.83
Activated intrarenal reactive oxygen species and renin angiotensin system in IgA nephropathy. Minerva Urol Nefrol (2009) 0.82
Induction of corneal myofibroblasts by lens-derived transforming growth factor beta1 (TGFbeta1): a transgenic mouse model. Brain Res Bull (2009) 0.82
Comparison of transforming growth factor beta expression in healthy and diseased human tendon. Arthritis Res Ther (2016) 0.81
Soluble biglycan as a biomarker of inflammatory renal diseases. Int J Biochem Cell Biol (2014) 0.80
Role of transforming growth factor-[beta]1 in inhibiting endothelial cell proliferation in experimental alcoholic liver disease. Am J Pathol (1996) 0.79
Roles of the Skp2/p27 axis in the progression of chronic nephropathy. Cell Mol Life Sci (2012) 0.78
Inhibition of Activin Signaling Slows Progression of Polycystic Kidney Disease. J Am Soc Nephrol (2016) 0.78
Levels of urinary transforming growth factor beta-1 in children with D+ hemolytic uremic syndrome. Pediatr Nephrol (2010) 0.77
Age-related differences in adriamycin-induced nephropathy. Pediatr Nephrol (2004) 0.77
Interaction of baboon anti-alpha-galactosyl antibody with pig tissues. Am J Pathol (1999) 0.77
The role of epigenetics in the fibrotic processes associated with glaucoma. J Ophthalmol (2014) 0.77
Urinary transforming growth factor beta1 in children and adolescents with congenital solitary kidney. Pediatr Nephrol (2008) 0.76
The challenge of renal function in heart transplant children. Pediatr Nephrol (2006) 0.76
Renal expression of advanced oxidative protein products predicts progression of renal fibrosis in patients with IgA nephropathy. Lab Invest (2014) 0.76
Inhibition of Thrombin-Activated Fibrinolysis Inhibitor Increases Survival in Experimental Kidney Fibrosis. J Am Soc Nephrol (2014) 0.76
Kinetics of transforming growth factor-beta1 and extracellular matrix in renal tubulointerstitial lesions of mercuric chloride-treated Brown Norway rats. Int J Exp Pathol (1999) 0.75
A Novel Interaction between FLICE-Associated Huge Protein (FLASH) and E2A Regulates Cell Proliferation and Cellular Senescence via Tumor Necrosis Factor (TNF)-Alpha-p21WAF1/CIP1 Axis. PLoS One (2015) 0.75
Higher plasma transforming growth factor (TGF)-β is associated with kidney disease in older community dwelling adults. BMC Nephrol (2017) 0.75
Genetic Considerations in Pediatric Chronic Kidney Disease. J Pediatr Genet (2015) 0.75
Differences in the timing and magnitude of Pkd1 gene deletion determine the severity of polycystic kidney disease in an orthologous mouse model of ADPKD. Physiol Rep (2016) 0.75
Reshaping the interstitium by platelet-derived growth factor. Implications for progressive renal disease. Am J Pathol (1996) 0.75
Kidney dysfunction in patients with pulmonary arterial hypertension. Pulm Circ (2017) 0.75
Transforming growth factor beta in tissue fibrosis. N Engl J Med (1994) 9.73
Natural inhibitor of transforming growth factor-beta protects against scarring in experimental kidney disease. Nature (1992) 3.96
Interaction of the small interstitial proteoglycans biglycan, decorin and fibromodulin with transforming growth factor beta. Biochem J (1994) 3.92
Expression of transforming growth factor beta is elevated in human and experimental diabetic nephropathy. Proc Natl Acad Sci U S A (1993) 3.16
Randomised clinical trial: Lactobacillus GG modulates gut microbiome, metabolome and endotoxemia in patients with cirrhosis. Aliment Pharmacol Ther (2014) 2.88
Renin increases mesangial cell transforming growth factor-beta1 and matrix proteins through receptor-mediated, angiotensin II-independent mechanisms. Kidney Int (2006) 2.85
Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-beta expression in rat glomerular mesangial cells. J Clin Invest (1994) 2.81
Elevated expression of transforming growth factor-beta and proteoglycan production in experimental glomerulonephritis. Possible role in expansion of the mesangial extracellular matrix. J Clin Invest (1990) 2.56
Antitubular basement-membrane antibodies in methicillin-associated interstitial nephritis. N Engl J Med (1974) 2.20
Nehprotic syndrome with glomerular mesangial IgM deposits. Lab Invest (1978) 2.19
Induction of membranous nephropathy in rabbits by administration of an exogenous cationic antigen. J Clin Invest (1982) 2.12
TGF-beta in kidney fibrosis: a target for gene therapy. Kidney Int (1997) 2.01
Gene therapy by skeletal muscle expression of decorin prevents fibrotic disease in rat kidney. Nat Med (1996) 1.93
Interactions of transforming growth factor-beta and angiotensin II in renal fibrosis. Hypertension (1998) 1.90
Expression of transforming growth factor-beta isoforms in human glomerular diseases. Kidney Int (1996) 1.81
Nitric oxide mediates immunologic injury to kidney mesangium in experimental glomerulonephritis. Lab Invest (1995) 1.79
Renin-stimulated TGF-beta1 expression is regulated by a mitogen-activated protein kinase in mesangial cells. Kidney Int (2007) 1.76
Gene therapy by transforming growth factor-beta receptor-IgG Fc chimera suppressed extracellular matrix accumulation in experimental glomerulonephritis. Kidney Int (1999) 1.76
Detection of circulating immune complexes in patients with glomerulonephritis. Kidney Int (1977) 1.66
Isolation of human and murine homologues of the Drosophila minibrain gene: human homologue maps to 21q22.2 in the Down syndrome "critical region". Genomics (1996) 1.58
Correlation and predictive accuracy of circulating immune complexes with disease activity in patients with systemic lupus erythematosus. Arthritis Rheum (1980) 1.56
A translocation interrupts the COL5A1 gene in a patient with Ehlers-Danlos syndrome and hypomelanosis of Ito. Nat Genet (1996) 1.46
Movement and pulse oximetry. Anaesthesia (1995) 1.41
Providing pharmaceutical care for indigent patients: a roundtable discussion. Am J Health Syst Pharm (2001) 1.40
Electrical charge. Its role in the pathogenesis and prevention of experimental membranous nephropathy in the rabbit. J Clin Invest (1983) 1.40
Glomerular matrix accumulation is linked to inhibition of the plasmin protease system. Kidney Int (1992) 1.32
Activation-dependent redistribution of the adhesion plaque protein, talin, in intact human platelets. J Cell Biol (1989) 1.25
A longitudinal study of brain atrophy in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG). Neurology (1999) 1.24
Frequent deletions of FHIT and FRA3B in Barrett's metaplasia and esophageal adenocarcinomas. Oncogene (1997) 1.23
IgA antibasement membrane nephritis with pulmonary hemorrhage. Ann Intern Med (1979) 1.22
Production of extracellular matrix by glomerular epithelial cells is regulated by transforming growth factor-beta 1. Kidney Int (1992) 1.21
Increased expression of transforming growth factor beta isoforms (beta 1, beta 2, beta 3) in bleomycin-induced pulmonary fibrosis. Am J Respir Cell Mol Biol (1995) 1.21
The murine Fhit gene is highly similar to its human orthologue and maps to a common fragile site region. Cancer Res (1998) 1.19
Coordinated expression of beta 1 integrins and transforming growth factor-beta-induced matrix proteins in glomerulonephritis. Lab Invest (1993) 1.18
Targeting TGF-beta overexpression in renal disease: maximizing the antifibrotic action of angiotensin II blockade. Kidney Int (1998) 1.18
Superoxide dismutase and catalase: a possible role in established pancreatitis. Am J Surg (1986) 1.09
A randomized trial to develop criteria for administering erythrocyte transfusions to anemic preterm infants 1 to 3 months of age. J Perinatol (1989) 1.06
Angiotensin II, TGF-beta and renal fibrosis. Contrib Nephrol (2001) 1.06
Limited joint mobility (LJM) of the hand in patients with diabetes mellitus: relation to chronic complications. Ann Rheum Dis (1986) 1.06
Evidence that TGF-beta should be a therapeutic target in diabetic nephropathy. Kidney Int (1998) 1.06
Enalapril and low protein reverse chronic puromycin aminonucleoside nephropathy. Kidney Int (1990) 1.05
Targeting TGF-beta for treatment of disease. Nat Med (1995) 1.03
Renal damage with intestinal bypass. Ann Intern Med (1978) 1.02
Integrins. Kidney Int Suppl (1994) 1.02
Dual effects of angiotensin II on the plasminogen/plasmin system in rat mesangial cells. Kidney Int (1997) 1.01
Outcome of pregnancy during imprisonment. J Reprod Med (1992) 1.00
In vivo interactions of TGF-beta and extracellular matrix. Prog Growth Factor Res (1992) 1.00
Antigenic changes as a determinant of immune complex localization in the rat glomerulus. Lab Invest (1981) 1.00
Failure of heparin to affect two types of experimental glomerulonephritis in rabbits. Kidney Int (1975) 0.99
Increased levels of transforming growth factor-beta in HIV-associated nephropathy. Kidney Int (1999) 0.99
Circulating immune complexes in rats with autologous immune complex nephritis. Lab Invest (1980) 0.98
Transforming growth factor-beta and matrix protein expression in acute and chronic rejection of human renal allografts. J Am Soc Nephrol (1995) 0.98
Cytokines and L-arginine in renal injury and repair. Am J Physiol (1994) 0.96
Dietary protein restriction rapidly reduces transforming growth factor beta 1 expression in experimental glomerulonephritis. Proc Natl Acad Sci U S A (1991) 0.96
Angiotensin II in renal fibrosis: should TGF-beta rather than blood pressure be the therapeutic target? Semin Nephrol (1997) 0.96
Studies of the metabolic basis of the ATP-DPG differences in genetically selected high and low ATP-DPG rat strains. Adv Exp Med Biol (1972) 0.96
Immune complex detection in glomerular diseases. Nephron (1979) 0.95
Transforming growth factor-beta and angiotensin II: the missing link from glomerular hyperfiltration to glomerulosclerosis? Annu Rev Physiol (1995) 0.95
Role of transforming growth factor-beta 1 in experimental chronic cyclosporine nephropathy. Kidney Int (1996) 0.95
Fibrosis linked to TGF-beta in yet another disease. J Clin Invest (1995) 0.95
Cytokines in kidney disease: the role of transforming growth factor-beta. Am J Kidney Dis (1993) 0.94
Quality of life assessment software for computer-inexperienced older adults: multimedia utility elicitation for activities of daily living. Proc AMIA Symp (2002) 0.93
Identification and analysis of the human and murine putative chromatin structure regulator SUPT6H and Supt6h. Genomics (1996) 0.93
Chromosomal localization of the ankyrinG gene (ANK3/Ank3) to human 10q21 and mouse 10. Genomics (1995) 0.92
Immune function and brain abnormalities in patients with systemic lupus erythematosus without overt neuropsychiatric manifestations. Lupus (2011) 0.92
Transforming growth factor-beta in human glomerular injury. Curr Opin Nephrol Hypertens (1997) 0.91
Non-specificity of circulating immune complexes in patients with acute and chronic liver disease. Clin Exp Immunol (1980) 0.91
Goodpasture syndrome treated with immunosuppression and plasma exchange. Arch Intern Med (1977) 0.91
Extracellular matrix/growth factor interactions. Cold Spring Harb Symp Quant Biol (1992) 0.91
Partial lipodystrophy, C3 nephritic factor and clinically inapparent mesangiocapillary glomerulonephritis. Am J Med (1977) 0.91
The canine copper toxicosis locus is not syntenic with ATP7B or ATX1 and maps to a region showing homology to human 2p21. Mamm Genome (1999) 0.90
t-PA promotes glomerular plasmin generation and matrix degradation in experimental glomerulonephritis. Kidney Int (2001) 0.90
Antagonists of transforming growth factor-beta: a novel approach to treatment of glomerulonephritis and prevention of glomerulosclerosis. Kidney Int (1992) 0.90
Transforming growth factor beta in diabetic nephropathy. Diabetes Metab Rev (1996) 0.90
Transforming growth factor-beta and extracellular matrix deposition in the kidney. Contrib Nephrol (1994) 0.90
A mutation of the atrial natriuretic peptide (guanylyl cyclase-A) receptor results in a constitutively hyperactive enzyme. Proc Natl Acad Sci U S A (1997) 0.89